Literature DB >> 10388633

Ischaemia and reperfusion during open abdominal aortic aneurysm surgery induce extensive thrombin generation and activity.

A Holmberg1, A Siegbahn, B Westman, D Bergqvist.   

Abstract

OBJECTIVES: does open surgery for abdominal aortic aneurysm (AAA) influence coagulation?
METHODS: in 23 patients operated on for AAA, cubital blood was sampled pre-, intra- and postoperatively. Femoral blood was also sampled intraoperatively.
RESULTS: preoperatively, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT) and soluble fibrin (SF) were elevated in AAA patients. During aortic clamping all parameters increased significantly in cubital blood (p<0.01) as well as in femoral blood (p<0.001) and after aortic declamping F1+2 and TAT increased further. F1+2, TAT and SF were significantly higher in femoral than cubital blood. Postoperatively F1+2 and TAT returned to preoperative values, while SF still had a significantly higher level than preoperatively (p<0.001). Blood loss showed co-variation with F1+2 increase in femoral blood after aortic declamping (p<0.05).
CONCLUSIONS: these data indicate that the coagulation system was strongly activated by the occurrence of an AAA. During AAA surgery a further extensive activation was seen. The activity was still high, but on decline, one week postoperatively. Ischaemia and reperfusion of the lower part of the body were the major stimuli for thrombin generation and activity. Copyright 1999 W. B. Saunders Company Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388633     DOI: 10.1053/ejvs.1999.0844

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  1 in total

Review 1.  The Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and Treatment.

Authors:  Aleksandra Piechota-Polanczyk; Alicja Jozkowicz; Witold Nowak; Wolf Eilenberg; Christoph Neumayer; Tadeusz Malinski; Ihor Huk; Christine Brostjan
Journal:  Front Cardiovasc Med       Date:  2015-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.